Quadratus Lumborum Block After Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19+
SponsorGangnam Severance Hospital

About this trial

This study aims to assess whether transmusculr quadratus lomborum block (QL block) can reduce postoperative pain after cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy (CRS and HIPEC). Patients will be randomly assigned to either QL block group or control group. Ultrasound-guided bilateral transmuscular quadratus lomborum block will be performed in QL block group using 0.375% ropivacaine. Multimodal analgesic regimen including acetaminophen, nonsteroidal antiinflammatory drugs (NSAIDs), and rescue opioids will be used in every patient. Primary outcome is opioid consumption for 24 hours after surgery. Secondary outcomes included pain scores, time to first rescue analgesics, quality of recovery score, length of hospital stay.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

Allergy to local anesthetics or fentanyl

Chronic pain

Drug abuse

Patients who are unable to use patient-controlled analgesia

Trial design

Design model

Parallel

Treatments tested in this trial

  • Arm I (QL block and multimodal analgesia), Arm II (multimodal analgesia without regional block)

    Procedure/Surgery

    Arm I (QL block and multimodal analgesia): Bilateral transmuscular QL block will be done. Postoperative multimodal analgesia including administration of acetaminophen, NSAIDs,nefopam, and rescue opioids Arm II (multimodal analgesia without regional block): No block will be done. Postoperative multimodal analgesia including administration of acetaminophen, NSAIDs, nefopam, and rescue opioids

Treatment groups

50 Participants
are divided into 2 treatment groups
Group A: QL block groupExperimental treatment 1 intervention
Group B: Control groupNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Total opioid consumption for 24 postoperative hours

Total opioid analgesic use for 24 hours after surgery (morphine milligram equivalents (MME))

Time frame
24 hours postoperatively

Secondary outcomes

1

Analgesic consumption

Analgesic consumption at postoperative 6, 12, 48, 72 hours

Time frame
at postoperative 6, 12, 48, 72 hours
2

Resting pain numeric rating scale(NRS)

Resting pain numeric rating scale(NRS) at postoperative 6, 12, 24, 48, 72 hours.

Time frame
at postoperative 6, 12, 24, 48, 72 hours
3

Numeric rating scale of pain during movement

Numeric rating scale of pain during movement at postoperative 6, 12, 24, 48, 72 hours

Time frame
at postoperative 6, 12, 24, 48, 72 hours
4

Time to first rescue analgesics

Time to first rescue analgesics

Time frame
within post-operative 24 hours

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.